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Received August 12, 2013; accepted November 29, 2013AbstractClinical deterioration during the treatment of tuberculosis remains a diagnostic challenge. We describe the case of a 46-year-old man with a
history of oral cancer status after a radical operation who had pulmonary tuberculosis with pleura and neck lymph node involvement. The
clinical condition improved after antituberculosis therapy. However, the patient suffered from low-grade fever, progressive dyspnea, and cough
after 7 weeks of the therapy. The findings of chest plain films were relapse and progression of left lung haziness. The deterioration was caused by
disseminated Penicillium marneffei infection. Disseminated P. marneffei in a non-HIV patient with tuberculosis is rarely seen, and the mani-
festations are similar to a paradoxical response and relapse of pulmonary tuberculosis, thereby making it difficult to establish a diagnosis.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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A paradoxical response is generally defined as the clinical
or radiological worsening of preexisting tuberculous lesions or
the development of new lesions in a patient who initially
improves with antituberculosis therapy, and is diagnosed only
after excluding any other possible diagnoses.1 Even though
Penicillium marneffei is the third most common opportunistic
infection in human immunodeficiency virus (HIV)-infected
patients in certain parts of Southeast Asia,2 it is a very rare
cause of paradoxical deterioration during antituberculosis
therapy in non-HIV patients. The symptoms of P. marneffei
infection are similar to those of pulmonary tuberculosis and aConflicts of interest: The authors declare that there are no conflicts of interest
related to the subject matter or materials discussed in this article.
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of a low suspicion and similar symptoms, and such a delay can
lead to worse outcomes. Herein, we present the case of a non-
HIV patient who deteriorated during antituberculosis treat-
ment and was later proven to have P. marneffei infection.
2. Case report
This 46-year-old man was a heavy smoker with a con-
sumption of two packs of cigarettes per day for >30 years, and
he also had the habit of betel nut chewing since adolescence.
He had always lived in Taiwan and had never traveled abroad.
His occupation was a street vendor selling fruits. He under-
went a radical operation for left buccal cancer pT2N0M0 in
June 2001. The postoperative course was smooth, and no
recurrence was found during regular follow-up. Except for the
operation, no other systemic diseases were noted until 2006.
He was admitted to our hospital in May 2006 with mani-
festations of nonproductive cough for 2 months, progressiveociation. All rights reserved.
259P.-H. Wang et al. / Journal of the Chinese Medical Association 78 (2015) 258e260dyspnea, and a body weight loss of 8 kg in 2 months. He denied
apparent fever and night sweating. Physically, multiple right
supraclavicular lymphadenopathies were noted. The white
blood cell count was 13,200, with an absolute lymphocyte
count of 2033, and the hemoglobulin level was 12.2 g/dL. AFig. 1. (A) Chest plain film in May 2006 shows haziness in the left lower lung
field, increased infiltrates in the right lower lung field, near the right hilum, and
suspicious upper mediastinal widening. (B) Chest plain film in September
2006 reveals a relapse of the left lung haziness after 7 weeks of antitubercu-
losis therapy. (C) Chest radiograph in October 2008 shows no apparent lung
lesions.chest plain film showed haziness in the left lower lung field,
increased infiltrates in the right lower lung field, and suspicious
upper mediastinal widening (Fig. 1A). Pleural effusion analysis
showed lymphocyte predominant exudates with 93% lympho-
cytes. Acid-fast staining (AFS) and cytology of the pleural
effusion were both negative. An incision biopsy of the right
supraclavicular lymphadenopathies showed chronic caseating
granulomatous inflammation with AFS bacilli. Anti- Myco-
bacterium tuberculosis (MTB) chemotherapy including isoni-
azid, rifampin, ethambutol, and pyrazinamide was prescribed.
Ethambutol was stopped after 1 week because of optic neuritis.
Sputum, pleural effusion, and tissue cultures all yielded MTB.
Chest radiography 1 month later showed much improvement.
However, similar symptoms including progressive dyspnea
and cough recurred in September 2006, after about 7 weeks of
anti-MTB therapy. Low-grade fever was noted, and breath
sounds were decreased, with crackles in the left lower chest.
The patient's liver and spleen were impalpable. Chest radiog-
raphy showed left lung haziness (Fig. 1B), and chest computed
tomography (CT) revealed consolidation in the left lower lobe
with pleural effusion and pleural thickening. The pleural
effusion still revealed exudates, with 67% lymphocytes, and
the cytology was negative for malignancy. No recurrence of
buccal cancer was found by the dentist. Drug compliance was
confirmed by directly observed therapy. Initially, treatment
failure of MTB or paradoxical response was suspected. We
prescribed kanamycin and moxifloxacin from hospital Day 4
and maintained the previous anti-MTB regimen. Prednisolone
20 mg per day was used from hospital Day 7 because of a
progression of the symptoms. In addition to the antecedent
manifestations, multiple skin nodules were noted in the left
anterior chest, left shoulder, and knees on hospital Day 9.
These skin nodules became enlarged under these medications.
A skin biopsy was done on hospital Day 13, and the pathologic
report revealed small-sized yeasts, with endospore-like ar-
rangements within giant cells and macrophages (Fig. 2).
Amphotericin B 0.6 mg/kg/d was substituted for moxifloxacin
and kanamycin, and systemic steroids were stopped on hos-
pital Day 16. A subsequent culture confirmed P. marneffei, andFig. 2. The skin biopsy microscopically reveals small-sized yeasts, with
endospore-like arrangements, demonstrated by periodic acid-Schiff staining
(arrows) and surrounded by giant cells and macrophages
(magnification  800).
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was substituted for amphotericin B because of a renal injury
after 7 days. Itraconazole 200 mg twice per day was given for
3 months after completion of 14-day amphotericin B therapy.
The patient recovered well after 3 months of antifungal and
6 months of anti-MTB therapies. The chest plain film in
December 2006 showed no apparent lung lesion (Fig. 1C).
3. Discussion
In this article, we present a non-HIV patient with dissem-
inated P. marneffei infection during pulmonary tuberculosis
treatment. Disseminated P. marneffei infection is seldom seen
in immunocompetent patients, even in endemic areas. It is
very rare for a non-HIV patient to have disseminated P.
marneffei infection. Some investigators have demonstrated
that non-HIV hosts without any immunosuppressant may have
impaired cell-mediated immunity, resulting from the
derangement of cytokine cascades, including overproduction
of suppressive cytokine, interleukin (IL)-10, and cytokine
deficiency in the IL-12/interferon-g pathway.3e6 This patient
did not undergo specific studies of cellular immunity defects
because of a lack of laboratory resources. However, concerns
about cellular immunity abnormalities of such a patient should
be kept in mind in spite of negative HIV serology and no
immunosuppressive therapy.
Taiwan is an endemic area of P. marneffei. Details of the
ecological reservoir of human P. marneffei remain unknown.7
There is a significantly seasonal variation in infection rates,
with an increased incidence in the rainy season.8 Some in-
vestigators have suggested that soil exposure, especially dur-
ing the rainy season, is a critical risk factor associated with
infection by P. marneffei.8 One typhoon in July 2006 and two
typhoons in August 2006 hit Taiwan, bringing substantial rain
and mudslides. In addition, our patient was a street vendor
selling fruits, durian in particular. He also had the habit of
betel nut chewing, and it is possible that both fruits and betel
nut may be contaminated by P. marneffei during rainy periods.
These conditions may increase the opportunity for P. marneffei
infection.
The presence of clinical deterioration is a great challenge in
the treatment course of anti-MTB chemotherapy. A paradox-
ical response is diagnosed only after other possible diagnoses
have been excluded. It is not a rare phenomenon, occurring in
6e30% of patients receiving antituberculosis therapy.9,10 The
onset of a paradoxical response from initiation of anti-
tuberculosis therapy ranges from weeks to months.10,11
Some investigators have suggested a number of risk factors
for a paradoxical response.10 However, these factors are not
crucial for a diagnosis of paradoxical response. For our pa-
tient, the tentative diagnosis was treatment failure or para-
doxical response after a series of initial work-ups because ofthe relatively subacute clinical course and lymphocyte pre-
dominant effusion. Nevertheless, the skin nodules hinted at a
differential diagnosis. Pulmonary tuberculosis and P. marneffei
share a similar symptomology and geographical distribution,12
however, two-thirds of disseminated P. marneffei infections
are characterized by skin lesions. The septate yeast-like or-
ganism seen in skin biopsy specimens is diagnostic of P.
marneffei,2 and the skin is the most common culture-positive
site.12
In conclusion, a paradoxical response can only be diagnosed
after all other possibilities have been excluded. Fungal in-
fections such as P. marneffei should be considered as a differ-
ential diagnosis, especially in endemic areas. Our case had M.
tuberculosis and P. marneffei infections sequentially, which is
very rare in a non-HIV patient. Such patients may have un-
identified defects of cellular immunity, or the cause may be
related to particular geographical or occupational factors.
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